Clearstead Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Hold
2025
Q2
Hold
2025
Q1
Hold
2024
Q4
Hold
2024
Q3
Sell
2024
Q2
$938 Sell
2024
Q1
$2.13K Buy
2023
Q4
$1.23K Sell
2023
Q3
$1.91K Buy